Urinary excretion of sulfapyridine in the rat - A relationship of the liver to urolithiasis

被引:20
作者
Scudi, JV
Robinson, HJ
机构
[1] Merck & Co Inc, Res Labs, Rahway, NJ USA
[2] Merck & Co Inc, Merck Inst Therapeut Res, Rahway, NJ USA
关键词
D O I
10.1097/00000441-194105000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:711 / 717
页数:7
相关论文
共 19 条
[1]  
Antopol W, 1939, P SOC EXP BIOL MED, V40, P428
[2]  
BAINES E. J., 1939, QUART JOUR PHARM AND PHARMACOL, V12, P4
[3]  
BRATTON AC, 1939, J BIOL CHEM, V12, P4
[4]  
Bueding E, 1939, P SOC EXP BIOL MED, V42, P464
[5]  
Gross P, 1939, P SOC EXP BIOL MED, V40, P448
[6]   The in vitro formation of an oxidizing agent by surviving tissues and sulfanilamide [J].
Harris, JS .
JOURNAL OF CLINICAL INVESTIGATION, 1939, 18 (05) :521-526
[7]   The formation of methemoglobin and sulfhemoglobin during sulfanilamide therapy [J].
Harris, JS ;
Michel, HO .
JOURNAL OF CLINICAL INVESTIGATION, 1939, 18 (05) :507-519
[8]  
KLEIN J. R., 1938, JOUR BIOL CHEM, V124, P613
[9]  
Lipschitz WL, 1939, J BIOL CHEM, V129, P333
[10]   Observations upon the experimental and clinical use of sulfapyridine. II. The treatment of pneumococcal pneumonia with sulfapyridine [J].
Long, PH ;
Wood, WB .
ANNALS OF INTERNAL MEDICINE, 1939, 13 (03) :487-512